A cross-sectional study of 227 patients in Uzbekistan finds that elevated hs-CRP and interleukin-6 levels are independently ...

Climb Bio's upcoming data readouts for its CLYM116 and budoprutug investigational therapies are likely to be more incremental and should help de-risk both programs, RBC Capital Markets said in ...

A combined network toxicology, machine learning, and experimental study has identified FABP3, PDE4B, and SLC1A3 as core ...

Vera Therapeutics, Inc. (Nasdaq: VERA), a commercial-stage biotechnology company, today announced that there will be multiple ...

Idiopathic membranous nephropathy (MN) shows variable renal outcomes, and reliable histologic markers for risk stratification are limited. The global sclerotic glomeruli ratio (GSGR) may reflect ...

Prolonged sleep habits are associated with a higher risk for incident or worsening diabetic nephropathy among patients with type 2 diabetes.

Dr Shikha Wadhwani emphasizes that this is an important time for nephrology: Better‑tolerated, more effective therapies for immunoglobulin (Ig)A nephropathy are now available. Her key advice to ...

No therapies currently exist that can halt the progression of chronic kidney disease in children or restore the ability of kidney cells to filter blood. Recently, researchers at the GOFARR Laboratory ...

Dr Shikha Wadhwani reflects on the limited treatment options for immunoglobulin (Ig)A nephropathy available when she began her career. At that time, management focused on blood-pressure control, ...

Diabetic nephropathy is the damage caused to the kidneys by diabetes mellitus. Around 50% of individuals with type 1 diabetes will develop nephropathy within 10 years of having the disease and around ...

Up to one-third of persons with type 1 or 2 diabetes mellitus will develop microalbuminuria or macroalbuminuria after 20 years. Smoking, poor glycemic control, male sex, older age, and ethnicity are ...

We report findings regarding a 56-year-old female patient with biopsy-proven membranous nephropathy, which was diagnosed in September 1999 and progressed to end-stage renal disease. In February 2004, ...